HS
ENZ

HighVista Strategies’s Enzo Biochem, Inc. ENZ Stock Holding History

HighVista Strategies’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-19,500
Closed -$51K – 122
2019
Q4 		$51K Hold
19,500
– – 0.04% 118
2019
Q3 		$70K Buy
+19,500
New +$69K 0.05% 97

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighVista Strategies's ENZ Position: Q1 2020 in Review

HighVista Strategies sold out of Enzo Biochem, Inc. (ENZ) in Q1 2020, closing a stake of 19,500 shares — an estimated $51K sold.

HighVista Strategies first reported a position in ENZ in Q3 2019 and held it in 2 quarters. The position peaked at $70K in Q3 2019. 76 funds tracked by Wall St. Rank hold ENZ as of Q1 2020.

  • HighVista Strategies reported no remaining Enzo Biochem, Inc. position as of Q1 2020 after selling out during the quarter.
  • HighVista Strategies sold 19,500 Enzo Biochem, Inc. shares in Q1 2020, an estimated $51K.
  • HighVista Strategies first reported a position in Enzo Biochem, Inc. in Q3 2019 and held it in 2 quarters.
  • HighVista Strategies's Enzo Biochem, Inc. position peaked at $70K in Q3 2019.
  • 76 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2020.

Based on HighVista Strategies's 13F filing for Q1 2020, filed 15 May 2020.